AbbVie Stock Forecast
NYSE: ABBVHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:02 PM ET · Delayed 15 min
After hours: 272.42 0.00%
ABBV analyst consensus
Consensus (30 analysts)
buy
Avg. price target
$280.79+3.07%
- Strong buy 8
- Buy 16
- Hold 5
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 30 Wall Street analysts covering AbbVie (2026-10-07), 24 rate the stock a buy or strong buy, 5 rate it a hold and 1 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $280.79, with a high estimate of $328.00 and a low estimate of $200.00. The average target implies upside of 3.1% from the current price of $272.42.
The spread between the highest and lowest targets is 64.0%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for ABBV.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 8 | 27% |
| Buy | 16 | 53% |
| Hold | 5 | 17% |
| Sell | 0 | 0% |
| Strong sell | 1 | 3% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $200.00 | -26.58% |
| Average target | $280.79 | +3.07% |
| High target | $328.00 | +20.40% |